Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Pain management company AlgoRx Pharmaceuticals raised $65mm through a Series C financing led by new investor Advent International. Returning backers InterWest Partners, JPMorgan Partners, and Sofinnova Ventures participated in the oversubscribed round along with additional new investors SR One, Pacific Rim Ventures, Index Ventures, Lehman Brothers Healthcare Fund, Hunt Ventures, EGS Healthcare Capital Partners, Piper Jaffray Ventures, NIF Ventures, Axiom Venture Partners, Cogene Biotech Ventures, and William Harris Investors.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?